Fellow Health Expands Mail-In Semen Analysis and Clinic Partnerships Across New York
Following New York conditional approval earlier this month, Fellow Health extends its mail-in semen analysis to fertility and urology practices statewide, deepening physician partnerships, embedding into clinical workflows, and expanding referral networks across the state
Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced expansion of its clinical partnerships across New York, making its comprehensive mail-in semen analysis available to fertility and urology practices statewide. The expansion follows Fellow Health’s New York State conditional approval earlier this month and reflects the company’s provider-first approach: integrating advanced semen analysis directly into clinical workflows rather than around them.
With New York conditional approval in place, fertility and urology clinicians can offer Fellow Health’s validated analysis as a managed extension of their own care, preserving continuity, supporting follow-up compliance, and keeping the provider at the center of the patient’s reproductive health journey. Orders originate with the physician, patients complete collection at home, and results return to the practice to inform clinical decision-making. By making testing easier and more accessible, this approach reduces time to treatment.
